These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17094436)

  • 1. Selective targeting of E. coli heat-stable enterotoxin analogs to human colon cancer cells.
    Giblin MF; Sieckman GL; Watkinson LD; Daibes-Figueroa S; Hoffman TJ; Forte LR; Volkert WA
    Anticancer Res; 2006; 26(5A):3243-51. PubMed ID: 17094436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical synthesis of Escherichia coli ST(h) analogues by regioselective disulfide bond formation: biological evaluation of an (111)In-DOTA-Phe(19)-ST(h) analogue for specific targeting of human colon cancers.
    Gali H; Sieckman GL; Hoffman TJ; Owen NK; Mazuru DG; Forte LR; Volkert WA
    Bioconjug Chem; 2002; 13(2):224-31. PubMed ID: 11906259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
    Giblin MF; Sieckman GL; Shelton TD; Hoffman TJ; Forte LR; Volkert WA
    Nucl Med Biol; 2006 May; 33(4):481-8. PubMed ID: 16720239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo comparison of human Escherichia coli heat-stable peptide analogues incorporating the 111In-DOTA group and distinct linker moieties.
    Giblin MF; Gali H; Sieckman GL; Owen NK; Hoffman TJ; Forte LR; Volkert WA
    Bioconjug Chem; 2004; 15(4):872-80. PubMed ID: 15264876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro evaluation of an 111In-labeled ST-peptide enterotoxin (ST) analogue for specific targeting of guanylin receptors on human colonic cancers.
    Gali H; Sieckman GL; Hoffman TJ; Kiefer GE; Chin DT; Forte LR; Volkert WA
    Anticancer Res; 2001; 21(4A):2785-92. PubMed ID: 11724355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of 111In-labeled E. coli heat-stable enterotoxin analogs for specific targeting of human breast cancers.
    Giblin MF; Gali H; Sieckman GL; Owen NK; Hoffman TJ; Volkert WA; Forte LR
    Breast Cancer Res Treat; 2006 Jul; 98(1):7-15. PubMed ID: 16724166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of human colorectal cancer using radiolabeled analogs of the uroguanylin peptide hormone.
    Liu D; Overbey D; Watkinson LD; Daibes-Figueroa S; Hoffman TJ; Forte LR; Volkert WA; Giblin MF
    Anticancer Res; 2009 Oct; 29(10):3777-83. PubMed ID: 19846908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of three 64Cu-labeled E. coli heat-stable enterotoxin analogues for PET imaging of colorectal cancer.
    Liu D; Overbey D; Watkinson LD; Smith CJ; Daibes-Figueroa S; Hoffman TJ; Forte LR; Volkert WA; Giblin MF
    Bioconjug Chem; 2010 Jul; 21(7):1171-6. PubMed ID: 20536242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells.
    Hoffman TJ; Gali H; Smith CJ; Sieckman GL; Hayes DL; Owen NK; Volkert WA
    J Nucl Med; 2003 May; 44(5):823-31. PubMed ID: 12732685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "To serve and protect": enzyme inhibitors as radiopeptide escorts promote tumor targeting.
    Nock BA; Maina T; Krenning EP; de Jong M
    J Nucl Med; 2014 Jan; 55(1):121-7. PubMed ID: 24287321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of an 111In-labeled ST-peptide analog for specific-targeting of human colon cancers.
    Gali H; Sieckman GL; Hoffman TJ; Owen NK; Chin DT; Forte LR; Volkert WA
    Nucl Med Biol; 2001 Nov; 28(8):903-9. PubMed ID: 11711309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.
    Chen J; Cheng Z; Owen NK; Hoffman TJ; Miao Y; Jurisson SS; Quinn TP
    J Nucl Med; 2001 Dec; 42(12):1847-55. PubMed ID: 11752084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C--specific ligand.
    Wolfe HR; Mendizabal M; Lleong E; Cuthbertson A; Desai V; Pullan S; Fujii DK; Morrison M; Pither R; Waldman SA
    J Nucl Med; 2002 Mar; 43(3):392-9. PubMed ID: 11884500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
    Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
    J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.
    Dijkgraaf I; Liu S; Kruijtzer JA; Soede AC; Oyen WJ; Liskamp RM; Corstens FH; Boerman OC
    Nucl Med Biol; 2007 Jan; 34(1):29-35. PubMed ID: 17210459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
    Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
    Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiolabeled divalent peptidomimetic vitronectin receptor antagonists as potential tumor radiotherapeutic and imaging agents.
    Harris TD; Cheesman E; Harris AR; Sachleben R; Edwards DS; Liu S; Bartis J; Ellars C; Onthank D; Yalamanchili P; Heminway S; Silva P; Robinson S; Lazewatsky J; Rajopadhye M; Barrett J
    Bioconjug Chem; 2007; 18(4):1266-79. PubMed ID: 17579472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice.
    Lo WL; Lo SW; Chen SJ; Chen MW; Huang YR; Chen LC; Chang CH; Li MH
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.
    Pitari GM; Di Guglielmo MD; Park J; Schulz S; Waldman SA
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7846-51. PubMed ID: 11438734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five Stabilized 111In-labeled neurotensin analogs in nude mice bearing HT29 tumors.
    Janssen PJ; de Visser M; Verwijnen SM; Bernard BF; Srinivasan A; Erion JL; Breeman WA; Vulto AG; Krenning EP; de Jong M
    Cancer Biother Radiopharm; 2007 Jun; 22(3):374-81. PubMed ID: 17651043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.